Impact of germline CHEK2 mutations on biochemical relapse free survival and metastasis free survival after radical treatment for patients with prostate cancer

by V. B. Matveev, A. A. Kirichek, A. V. Savinkova, A. V. Khachaturyan, D. A. Golovina, L. N. Lyubchenko
Published 2019-01-01

INHIBITION OF REDD1 EXPRESSION FOR THE REDUCTION OF GLUCOCORTICOID-INDUCED SIDE EFFECTS

by E. S. Lylova, A. V. Savinkova, E. M. Zhidkova, K. I. Kirsanov, M. G. Yakubovskaya, I. V. Budunova, E. A. Lesovaya
Published 2020-12-01

COMPARATIVE ANALYSIS OF BIOLOGICAL EFFECTS OF SELECTIVE ACTIVATOR OF THE GLUCOCORTICOID RECEPTOR CPDA ON DIFFERENT SUBTYPES OF BREAST CANCER CELL LINES

by E. M. Zhidkova, K. A. Kuzin, L. R. Tilova, A. V. Savinkova, O. I. Borisova, M. D. Lavrova, V. P. Maximova, K. I. Kirsanov, M. G. Yakubovskaya, E. A. Lesovaya
Published 2017-12-01

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT

by A. V. Savinkova, E. M. Zhidkova, L. R. Tilova, M. D. Lavrova, E. S. Lylova, K. A. Kuzin, A. Yu. Portyannikova, V. P. Maximova, A. V. Kholodova, O. A. Vlasova, T. I. Fetisov, K. I. Kirsanov, G. A. Belitskiy, M. G. Yakubovskaya, E. A. Lesovaya
Published 2018-07-01